| Metric | Q3 2026 | Q2 2026 | Q3 2025 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $909M | $905M | — | 0.5% | — |
| Op. Income | $176M | $181M | — | -2.9% | — |
| Gross Margin | 31.7% | 32.4% | — | -0.7pp | — |
| Net Margin | 14.4% | 16.2% | — | -1.8pp | — |
| EPS (Diluted) | $0.85 | $0.97 | — | -12.4% | — |
| Free Cash Flow | $121M | $171M | — | -29.7% | — |
| Item | Amount |
|---|---|
| REVENUE | $909M |
| Cost of Revenue | $621M |
| GROSS PROFIT | $288M |
| R&D Expenses | $29M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $83M |
| Other Expenses | $0 |
| Operating Expenses | $112M |
| Cost & Expenses | $733M |
| OPERATING INCOME | $176M |
| Interest Income | $0 |
| Interest Expense | $339.0K |
| Other Income/Expenses | $4M |
| INCOME BEFORE TAX | $180M |
| Income Tax Expense | $49M |
| Net Income from Continuing Ops | $131M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $131M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $131M |
| D&A | $8M |
| EBIT | $181M |
| EBITDA | $189M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $909M |
| Cost of Revenue | $621M |
| GROSS PROFIT | $288M |
| R&D Expenses | $29M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $83M |
| Other Expenses | $0 |
| Operating Expenses | $112M |
| Cost & Expenses | $733M |
| OPERATING INCOME | $176M |
| Interest Income | $0 |
| Interest Expense | $339.0K |
| Other Income/Expenses | $4M |
| INCOME BEFORE TAX | $180M |
| Income Tax Expense | $49M |
| Net Income from Continuing Ops | $131M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $131M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $131M |
| D&A | $8M |
| EBIT | $181M |
| EBITDA | $189M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $131M |
| Depreciation & Amortization | $8M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $2M |
| Change in Working Capital | -$16M |
| OPERATING CASH FLOW | $125M |
| Capital Expenditure | -$5M |
| Acquisitions (Net) | -$8M |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$3M |
| NET CASH FROM INVESTING | -$16M |
| Net Debt Issuance | -$2M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$197.0K |
| NET CASH FROM FINANCING | -$2M |
| FREE CASH FLOW | $121M |
| Net Change in Cash | $107M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $953M |
| Short-Term Investments | $0 |
| Net Receivables | $1.2B |
| Inventory | $275M |
| Other Current Assets | $135M |
| TOTAL CURRENT ASSETS | $2.6B |
| PP&E (Net) | $85M |
| Goodwill | $485M |
| Intangible Assets | $81M |
| Long-Term Investments | $0 |
| Tax Assets | $518M |
| Other Non-Current Assets | $72M |
| TOTAL NON-CURRENT ASSETS | $1.2B |
| TOTAL ASSETS | $3.8B |
| Account Payables | $560M |
| Short-Term Debt | $0 |
| Deferred Revenue | $322M |
| Other Current Liabilities | $203M |
| TOTAL CURRENT LIABILITIES | $1.1B |
| Long-Term Debt | $0 |
| Deferred Revenue NC | $98M |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $467M |
| TOTAL NON-CURRENT LIABILITIES | $564M |
| TOTAL LIABILITIES | $1.6B |
| Common Stock | $15.0K |
| Additional Paid-In Capital | $0 |
| Retained Earnings | -$2.1B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$656.0K |
| Other Equity | $4.3B |
| TOTAL STOCKHOLDERS' EQUITY | $2.2B |
| Minority Interest | $0 |
| TOTAL EQUITY | $2.2B |
| TOTAL LIABILITIES & EQUITY | $3.8B |
| Total Debt | $0 |
| Net Debt | -$953M |
